
The results from the in vivo animal study also suggest sex-specific responses to cannabinol (CBN).
Study Finds Medical Cannabis Significantly Reduces Emergency and Urgent Care Visits for Chronic Pain Patients
Study Finds US Physicians Feel Underprepared to Guide Patients on Medical Cannabis
The results from the in vivo animal study also suggest sex-specific responses to cannabinol (CBN).
In this interview clip from our Higher Education: Research Initiatives That Deepen Our Understanding of Cannabis supplement, Carrie Cuttler, PhD explains the administrative hurdles, strict regulations, and other barriers to cannabis research.
According to a recent study, low THC cannabis extracts could be a potential tool for children diagnosed with Rett Syndrome.
In this interview clip from our Higher Education: Research Initiatives That Deepen Our Understanding of Cannabis supplement, Carrie Cuttler, PhD, describes results from a recent placebo-controlled FDA-approved clinical trial on THC’s impact on memory.
Here, we bring you our top five recent articles covering revoking medical cannabis cards in Florida, testing and sampling initiative in Missouri, our mid-year regulations roundup, depenalization ordinance stopped in Texas, and accuracy in THC labeling in flower versus concentrates.
In this interview clip from our Higher Education: Research Initiatives That Deepen Our Understanding of Cannabis supplement, Carrie Cuttler, PhD, explains the goals and projects of the Center for Cannabis Policy Research and Outreach at Washington State University.
Data from a recent study discovered that THC labeling was more accurate in concentrate products than with cannabis flower.
Despite federal hurdles, WSU researchers at the Center for Cannabis Policy Research and Outreach (CCPRO) are expanding cannabis science and collaboration.
Daniela Vergara, PhD, discusses her work with on the production of photo periods and the importance of data sharing.
We’re halfway through 2025, so let’s revisit the top five articles this year covering research, regulations, and other industry insights.
The results highlight gender disparities, uncertainty about vape contents, and the growing use of synthetic products.
Daniela Vergara, PhD, explains her work with the Cornell Cooperative Extension.
Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.
Results included improvements in aggression, hyperactivity, and communication, but a strong placebo effect was also observed.
Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.
The study tested the effects of real-world cannabis products categorized by four modes of administration: dabbing, vaping, bong-like, or joint-like products.
A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.
A recent study found that CBD gummies may not have accurate labeling on how much the cannabinoid it contains.
Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.
Researchers analyzed national data over a 16-year timeframe to identify who receives treatment for cannabis use disorder (CUD).
The cannabinoids cannabidiol (CBD) and cannabidivarin (CBDV) showed antifungal activity in both in vivo tests and in vitro wound models.
Daniela Vergara, PhD, discusses the high genetic diversity of the cannabis genome and data legal challenges.
Nearly halfway through 2025, let’s revisit what new scientific updates and insights have been happening in the industry.
Here, we bring you our top five recent articles covering hemp restrictions in Alabama and Texas, data on medical cannabis patients and sleep apnea, FDA making psychedelics a top priority, and research on cannabis use and sperm quality.
Researchers analyzed data from 262 counties, identifying sociodemographic characterizations, associations, and discrepancies.